Development of vaccines for endemic diseases

DR. JAY SHINDE | October 16, 2016

article image
The Prime Minister of India, Mr. Narendra Modi, took a trip to the USA, and amongst the various activities he was involved in, also had a very fruitful meeting with the US President, Mr. Obama. The talks centred around the biotechnology and health services sectors, with emphasis on developing longterm solutions for endemic diseases in India. The health issues taken up on priority are Dengue, Malaria and Tuberculosis, and the mode of action will be to develop vaccines in order to prevent these conditions.

Spotlight

CoHealth (Formerly Dash MD)

CoHealth is a patient access platform delivered to patients in any healthcare setting. We capture patient attention through our personal health manager by partnering with health providers to create customized, digital care pathways for a variety of health related conditions. We then use patient attention to drive insights and value to our partners to promote organizational efficiencies and strategic decision making.

OTHER ARTICLES

Coronavirus Pandemic Brings Hundreds Of U.S. Clinical Trials To A Halt

Article | April 11, 2020

Rene Roach fired off a quick email in late March for an update on a colorectal cancer clinical trial for which she hoped to qualify. Worried about the coronavirus, she asked, almost as an afterthought, whether the study had been put on hold because of the pandemic.The answer crushed her: It had been. "That's when COVID-19 shut down everything," says Roach, 50, of Germantown, Md. Roach assumed that there would be workarounds for patients like her, who have stage IV cancer. These patients often depend on clinical trials as their best chance to knock cancer out when other therapies have failed. For now, she's being treated with traditional chemotherapy, but she was counting on the drug cocktail from the clinical trial. She figures if chemo was going to rid her body of cancer for good, it would have done so already.

Read More

Decentralized Clinical Trials: Imperative for Pharma Sector to fight COVID19

Article | April 11, 2020

These are unprecedented times. The world is mobbed by a contagion virus, putting people’s health at risk, threatening to destabilize economies. It has already put global healthcare systems under tremendous pressures, and managed to resist efforts to contain it. Even though coronaviruses are not new, this COVID-19 strain has created panic and forced us to be locked down in our homes sans any movement for weeks, if not months. Organizations are fighting an intense battle to keep their workforce safe, minimize risk, and ensure business continuity. For the Life Sciences industry, however, the challenge is even more significant. The whole world is looking at them to come up with a vaccine and a cure. But that is easier said than done. Bringing a new drug to market is an uphill battle and requires rigorous clinical trials. This process already has regulatory challenges. With the current lockdown situation, the Pharma community is grappled with the challenge of continuing some of the critical and time-sensitive in-flight trials so that their regulatory submission, registration, and market entry are not impacted. But all may not be lost. With the right technology solution, it is possible to turn the situation around rapidly.

Read More

WANT LESS “LIABILITY” AND MORE “RELIABILITY” FROM YOUR CLINICAL MOBILITY SOLUTION?

Article | April 11, 2020

I recently discussed the different ways that consumer-grade smartphones can compromise patients’ health, safety and overall care. However, some clinicians and healthcare administrators have indicated in recent months that they need help selecting the right enterprise-grade mobility solutions for their unique operating models and workflows. There are many different hardware and software options, and a single rugged device can come in multiple configurations. So, how do you know if you’re picking the right communication tools for your clinicians? The key is to first set performance expectations for the total mobility solution rather than the device alone.

Read More

Clinical Supply Availability & Speed to Study Start-Up

Article | April 11, 2020

If you’re part of a clinical study team racing a new product to commercialization, you likely live by these two simple rules: time is money, and the first one to market wins. But just because it’s simple doesn’t mean it’s easy. That ticking clock is background noise to the responsibilities of regulations, study protocols, supply chains, and patient recruitment — all the details that must be worked out before a study can even begin. The pressure is always there. The longer it takes for a study to start, the longer it takes to complete.

Read More

Spotlight

CoHealth (Formerly Dash MD)

CoHealth is a patient access platform delivered to patients in any healthcare setting. We capture patient attention through our personal health manager by partnering with health providers to create customized, digital care pathways for a variety of health related conditions. We then use patient attention to drive insights and value to our partners to promote organizational efficiencies and strategic decision making.

Events